Madrigal Pharmaceuticals Inc. (MDGL)

237.82 -0.43 (-0.18%)

IEX Real-Time Price

August 17, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 238.25

Price Open 238.25

Volume: 109,244

Avg Volume: 191,078

Market Cap: 3.65B

P/E Ratio -105.7

52 Wk Range 15.53-325.98





MDGL Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-10
Q1 2018
N/A
-0.77 (2)
0.00
0.00

2018-05-08
Q1 2018
N/A
-0.75 (3)
-0.45
0.30

2018-04-02
Q4 2017
N/A
-0.68 (2)
0.00
0.00

2018-03-13
Q4 2017
N/A
-0.68 (2)
-0.67
0.01

News

Premarket analyst action - healthcare (2018-08-06 07:57 SeekingAlpha)

Alder Biopharmaceuticals (NASDAQ: ALDR ) initiated with Overweight rating and $28 (47% upside) price target at Piper Jaffray. More news on: Alder Biopharmaceuticals Inc., Global Blood Therapeutics, Sage Therapeutics, Healthcare stocks news, Stocks on the move, , Read more …

 

Viking Therapeutics: A Strong Grower To Service The Lucrative NASH Market (2018-08-06 06:21 SeekingAlpha)

You are neither right nor wrong because the crowd disagrees with you. You are right because your data and reasoning are right. - Benjamin Graham Viking Therapeutics (NASDAQ: VKTX ) is a highly promising grower alerted to us by members of Integrated BioSci Investing. The stock enjoyed a s…

 


Statistics

Shares Outstanding: 15.37M

Top 15 Institution Percent: 42.30

Price To Sales: N/A

Price To Book: 7.52

Revenue: N/A

Gross Profit: N/A

Cash: 62.14M

Debt: N/A

Return On Assets: -10.59

Return On Equity: -10.82

Profit Margin: N/A

Price History

Beta: 1.25

50-day Moving Avg: 275.10

200-day Moving Avg: 151.16

YTD Change: 144.12

5-day Change: 5.04

1-month Change: -17.22

3-month Change: 82.13

6-month Change: 74.93

1-year Change: N/A

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Madrigal Pharmaceuticals Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.madrigalpharma.com

Madrigal Pharmaceuticals Inc is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH).